OPK Biotech  
OPK Biotech websites
Company Technology Research & Development Hemopure Oxyglobin Contact OPK Biotech
Technology & Products - Innovative Research in Oxygen Therapeutics
Home > Research & Development > Ischemia

Ischemia

Ischemia - a decrease or lack of red blood cell flow to an organ or area of the body due to obstructed or constricted blood vessels, as in heart attack, stroke and certain medical procedures.

Our development strategy for ischemia is to assess Hemopure's safety and feasibility in ischemia indications, such as cardiac surgery, wound healing and acute coronary ischemia (e.g. heart attack). In contrast to previous uses where Hemopure was administered as a red blood cell replacement, here it would be used as an oxygen-carrying drug.

HBOCLAB.com
is a Resource Guide for individuals interested in the impact of OPK Biotech's Hemoglobin Based Oxygen Carriers (HBOCs) on laboratory assays. The information presented for Hemopure® also applies to Oxyglobin®.

Learn More
Hemopure
Hemopure® has been used to treat surgical anemia in South Africa since 2001.

Learn More

Oxyglobin
Oxyglobin® Solution

More than
200,000 units
have been
sold in the
United
States and
Europe.

Learn More